161 related articles for article (PubMed ID: 17057085)
1. Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice.
Reiling L; Jacobs T; Kroemer M; Gaworski I; Graefe S; Clos J
Infect Immun; 2006 Nov; 74(11):6027-36. PubMed ID: 17057085
[TBL] [Abstract][Full Text] [Related]
2. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
Elso C; Kumar B; Smyth G; Foote S; Handman E
Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
[TBL] [Abstract][Full Text] [Related]
4. Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines.
Carrión J; Folgueira C; Alonso C
Vaccine; 2008 Feb; 26(9):1155-65. PubMed ID: 18255202
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
Shimizu Y; Takagi H; Nakayama T; Yamakami K; Tadakuma T; Yokoyama N; Kojima N
Parasite Immunol; 2007 May; 29(5):229-39. PubMed ID: 17430546
[TBL] [Abstract][Full Text] [Related]
6. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
7. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis.
Weiss R; Scheiblhofer S; Thalhamer J; Bickert T; Richardt U; Fleischer B; Ritter U
Vaccine; 2007 Jan; 25(1):25-33. PubMed ID: 17064826
[TBL] [Abstract][Full Text] [Related]
8. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
[TBL] [Abstract][Full Text] [Related]
9. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.
Vanloubbeeck Y; Jones DE
Am J Trop Med Hyg; 2004 Oct; 71(4):407-11. PubMed ID: 15516635
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of macrophages expressing MRP8 and MRP14 in skin lesions during Leishmania major infection in BALB/c and RAG-2 knockout mice.
Goto Y; Sanjoba C; Arakaki N; Okamoto M; Saeki K; Onodera T; Ito M; Matsumoto Y
Parasitol Int; 2007 Sep; 56(3):231-4. PubMed ID: 17409015
[TBL] [Abstract][Full Text] [Related]
11. The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds.
Gumy A; Louis JA; Launois P
Int J Parasitol; 2004 Mar; 34(4):433-44. PubMed ID: 15013733
[TBL] [Abstract][Full Text] [Related]
12. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
[TBL] [Abstract][Full Text] [Related]
13. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
Arendse B; Van Snick J; Brombacher F
J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
[TBL] [Abstract][Full Text] [Related]
14. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice.
Jaafari MR; Ghafarian A; Farrokh-Gisour A; Samiei A; Kheiri MT; Mahboudi F; Barkhordari F; Khamesipour A; McMaster WR
Vaccine; 2006 Jul; 24(29-30):5708-17. PubMed ID: 16740346
[TBL] [Abstract][Full Text] [Related]
15. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
16. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
Aguilar-Torrentera F; Carlier Y
Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
[TBL] [Abstract][Full Text] [Related]
17. Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite.
Hübel A; Krobitsch S; Hörauf A; Clos J
Mol Cell Biol; 1997 Oct; 17(10):5987-95. PubMed ID: 9315657
[TBL] [Abstract][Full Text] [Related]
18. Persistence without pathology in phosphoglycan-deficient Leishmania major.
Späth GF; Lye LF; Segawa H; Sacks DL; Turco SJ; Beverley SM
Science; 2003 Aug; 301(5637):1241-3. PubMed ID: 12947201
[TBL] [Abstract][Full Text] [Related]
19. Leishmania sp. isolated from human cases of cutaneous leishmaniasis in Brazil characterized as Leishmania major-like.
Silva Sde O; Wu AA; Evans DA; Vieira LQ; Melo MN
Acta Trop; 2009 Dec; 112(3):239-48. PubMed ID: 19660430
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes.
Lipoldová M; Svobodová M; Krulová M; Havelková H; Badalová J; Nohýnková E; Holán V; Hart AA; Volf P; Demant P
Genes Immun; 2000 Feb; 1(3):200-6. PubMed ID: 11196712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
